US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.80

+0.02710.08%

Post-market: 33.800.00000.00%16:10 EDT

Volume:222

Turnover:8K

Market Cap:13.52M

PE:- -

High:33.80

Open:33.77

Low:33.80

Close:33.77

52wk High:34.98

52wk Low:27.25

Shares:400.00K

Float Shares:400.00K

Volume Ratio:0.14

T/O Rate:0.06%

Dividend:0.08

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Surrozen price target raised to $54 from $44 at H.C. Wainwright

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Advances 7.0%, Outperforms Peers

Nanobiotix advances cancer nanotherapeutics and bolsters cash runway into 2029

France's Nanobiotix H1 Net Loss Widens on Lower Revenue, Absence of 2025 One-Off Gain

Press Release: Nanobiotix Provides First Half 2026 Operational and Financial Update

FDA approves Welireg and Lenvima combo for ccRCC

Merck Shares Flat in Volume Spike After FDA Approves Kidney Drug, Last up 0.50% at $148.81

THOMSON REUTERS

FDA Approves Belzutifan in Combination with Lenvatinib for Advanced Renal Cell Carcinoma with a Clear Cell Component

THOMSON REUTERS

Merck Has Two Overlooked Pipeline Catalysts Coming Before Year-End, UBS Says

MT Newswires Live

Alert on EOG CFO Appointment Incorrectly Tagged to J&J Withdrawn

EOG Resources Announces Ann Janssen's Retirement and Jeff Hibbard as Next CFO

THOMSON REUTERS

CSPC Pharma's JMT101 Combined with Osimertinib Achieves Positive Topline Results in Phase III Trial for First-Line Treatment of EGFR ex20ins NSCLC

Merck's Drug for Diabetes-Related Eye Disease Meets Trial Goal

Press Release: Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (fshd) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development

Merck Says Remigromig Meets Primary Endpoint in Pivotal Brunello Trial for Diabetic Macular Edema

Merck & Co - Higher Rates of Pdr, Vitreous Hemorrhage, and Discontinuations with Remigromig

THOMSON REUTERS

Merck’s Remigromig, a Tri-Specific Agonist of the Wingless-Related Integration Site (Wnt) Pathway, Met Primary Endpoint in the Pivotal Phase 2B/3 Brunello Study of Adults with Diabetic Macular Edema

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BMED/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.7958,"timestamp":1790971200000,"preClose":33.7687,"halted":0,"volume":222,"hourTrading":{"tag":"盘后","latestPrice":33.7958,"preClose":33.7958,"latestTime":"16:10 EDT","volume":6,"amount":202.7748,"timestamp":1790971804498,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0008025183083742411,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Post-Mkt","change":0.0271,"latestTime":"10-02 19:46:02 EDT","open":33.7687,"high":33.7958,"low":33.7958,"amount":7529,"amplitude":0,"askPrice":50.65,"askSize":200,"bidPrice":16.89,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790985600000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":33.7687,"sharesOutstanding":360000,"nav":34.496841,"aum":13798736.4,"dividendRate":0.002361,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.7958,"preClose":33.7958,"latestTime":"16:10 EDT","volume":6,"amount":202.7748,"timestamp":1790971804498,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.136548,"impliedVol":0.2698,"impliedVolPercentile":0.7331},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.136548,"shares":400000,"dividePrice":0.0798,"high":33.7958,"amplitude":0,"preClose":33.7687,"low":33.7958,"week52Low":27.25,"pbRate":"--","week52High":34.98,"institutionHeld":0,"latestPrice":33.7958,"eps":0,"divideRate":0.002361,"volume":222,"delay":0,"ttmEps":0,"open":33.7687,"prevYearClose":30.32,"prevWeekClose":34.7637,"prevMonthClose":34.561,"prevQuarterClose":34.561,"fiveDayClose":34.7637,"twentyDayClose":34.42,"sixtyDayClose":31.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670444358","title":"Surrozen price target raised to $54 from $44 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2670444358","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670444358?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:10","pubTimestamp":1790331041,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Surrozen (SRZN) to $54 from $44 and keeps a Buy rating on the shares. The firm believes Merck’s (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/surrozen-price-target-raised-to-54-from-44-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/surrozen-price-target-raised-to-54-from-44-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VHT","LU0208291251.USD","XLV","LU1093756168.USD","IHE","PPH","LU1116320901.HKD","FHLC","TRUH","IE00BLSP4239.USD","LU1917777945.USD","LU2360032135.SGD","LU1941712348.USD","LU0265550946.USD","LU2361044949.HKD","SG9999002224.SGD","LU0965508806.USD","LU1934455277.USD","LU2125909247.SGD","LU0070302665.USD","IYH","HRTS","LU1093756325.SGD","LU2361044865.SGD","JDOC","LU1023059063.AUD","RXL","LU1989772923.USD","PAWZ","SG9999015341.SGD","SRZN","BMED","LU0130102774.USD","LU2433249047.HKD","LU0057025933.USD","LU2491049909.HKD","LU0689626769.HKD","LU0289961442.SGD","BK4588","LU0823416689.USD","LU1923622614.USD","LU1069347547.HKD","LU1934455863.HKD","MRK","LU2361045086.USD","IXJ","LU1035773651.USD","FTXH","LU1037948897.HKD","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413314","title":"Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413314","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413314?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:55","pubTimestamp":1790283300,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  slipped 3.50% to $95.37 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Estee Lauder Cos. Cl A closed 21.59% below its 52-week high of $121.64, which the company reached on February 3rd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.56% to $270.68, Procter & Gamble Co.  fell 1.16% to $145.68, and Coty Inc. Cl A  fell 0.38% to $2.63.Trading volume  eclipsed its 50-day average volume of 3.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","LU1043141396.HKD","TRUH","IE00BFTCPJ56.SGD","LU2264538146.SGD","LU2552382132.HKD","LU2750360641.GBP","SG9999014575.USD","IE00BBT3K403.USD","LU0942090050.USD","RXL","BK4585","VHT","COTY","FTXH","BMED","TRUO","IE00B1XK9C88.USD","IYH","LU0795875169.SGD","LU1674673428.USD","IHE","JNJ","LU0738911758.USD","SG9999014542.SGD","IXJ","LU1585245621.USD","LU1066051811.HKD","PG","LU2347655156.SGD","MEDX","EL","LU0553294199.USD","PJP","BK4533","LU2592432038.USD","IE000MB6IJN5.SGD","JDOC","IE000BZT7R73.USD","LU1914381329.SGD","LU0057025933.USD","XLP","IE00BSNM7G36.USD","FHLC","GLAM","UGE","XLV","IE0034235303.USD","FSTA","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413895","title":"Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413895?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:50","pubTimestamp":1790283042,"startTime":"0","endTime":"0","summary":"Health Rounds: Genetic discovery yields clues toward reversal of Alzheimer's brain damageSept 24 -Hello Health Rounds readers!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL1N45G0ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU1585245621.USD","IE00B7SZLL34.SGD","BK4585","LU2324357040.USD","LU0289739699.SGD","MEDI","LU2087621335.USD","LU0122379950.USD","LU1023059063.AUD","LU1934455194.USD","LU0823416689.USD","IE00B19Z3B42.SGD","BBH","GILD","BK4588","TMED","BK4583","LU0965509010.AUD","LU1037948541.HKD","IE00BSNM7G36.USD","LU0234570918.USD","LU1061106388.HKD","BK4532","IE0002270589.USD","LU1934455863.HKD","BIB","BMED","BK4550","TBXU","IBBQ","SG9999015952.SGD","LU1934455277.USD","LU0861579265.USD","LU2357627491.SGD","LU0058720904.USD","LU1037948897.HKD","LU1674673428.USD","BK4568","BK4139","SG9999015945.SGD","LU0882574055.USD","IE00BKVL7J92.USD","LU0965509101.SGD","IBB","LU2089984988.USD","SG9999015978.USD","BK4578","IE00B19Z3581.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670180864","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670180864","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670180864?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:35","pubTimestamp":1790282100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.11% to $149.69 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 4.83% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.56% to $270.68, Pfizer Inc.  rose 0.82% to $28.41, and Abbott Laboratories  fell 2.34% to $101.07.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","BK4585","IE0002270589.USD","LU0122379950.USD","LU0965509101.SGD","BK4532","BK4566","GILD","LU1585245621.USD","IE00B19Z3581.USD","TMED","BK4139","TBXU","BMED","IE00B7SZLL34.SGD","LU0965509283.SGD","LU1037948897.HKD","LU2089984988.USD","LU0889565916.HKD","LU0965509010.AUD","LU0320765992.SGD","LU0861579265.USD","SG9999015986.USD","LU1674673428.USD","LU0965508806.USD","SG9999015945.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","LU0289739699.SGD","LU1061106388.HKD","BK4568","LU2087621335.USD","LU1037948541.HKD","MEDI","BIB","IE00B3T34201.USD","LU1571399168.USD","IE00B19Z3B42.SGD","LU2357627491.SGD","SG9999015952.SGD","SG9999015978.USD","IBB","LU1674673691.USD","BK4583","LU1778281490.HKD","LU1839511570.USD","LU1066051498.USD","LU0234570918.USD","BBH","LU0109394709.USD","LU2112291526.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU1057294990.SGD","BK4550","BK4588","LU1934455194.USD","LU1934455863.HKD","LU2468319806.SGD","LU1934455277.USD","LU0882574055.USD","LU1430594728.SGD","LU2324357040.USD","LU0058720904.USD","LU0859254822.USD","LU1023059063.AUD","LU0823416689.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670184794","title":"Moderna Inc. Stock Advances 7.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670184794","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670184794?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:33","pubTimestamp":1790281980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 7.0% to $194.82 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 26,939.37 and the Dow Jones Industrial Average falling 0.3% to 51,349.98.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $192.31, which the company reached on September 23rd.The stock outperformed some of its peers, as Johnson & Johnson rose 0.6% to $270.68, Pfizer Inc. rose 0.8% to $28.41, and Gilead Sciences Inc. fell 1.11% to $149.69.Trading volume totaled 16.4 million, compared to the 50-day average of 18.6 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMED","LU0965509101.SGD","BIB","LU2468319806.SGD","BK4534","BK4550","MRNX","LU0861579265.USD","GNOM","TBXU","LU0234570918.USD","LU1430594728.SGD","LU1066051498.USD","LU2112291526.USD","BK4532","LU0965509283.SGD","LU1057294990.SGD","LU1066053197.SGD","BMED","BBH","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU2324357040.USD","IBBQ","LU0965508806.USD","LU1674673428.USD","LU0965509010.AUD","BK4568","WDNA","IE0002270589.USD","MEDI","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU2357627491.SGD","BK4533","IBB","IE00B3T34201.USD","LU0289739699.SGD","LU1778281490.HKD","IE00B19Z3B42.SGD","LGHT","LU0859254822.USD","GILD","MRNA","SG9999015952.SGD","LU1934455863.HKD","MRNY","LU1571399168.USD","BK4551","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670187634","title":"Nanobiotix advances cancer nanotherapeutics and bolsters cash runway into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2670187634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670187634?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:32","pubTimestamp":1790281948,"startTime":"0","endTime":"0","summary":"Nanobiotix ( ($FR:NANO) ) just unveiled an announcement. Nanobiotix reported encouraging clinical progress for its lead nanoradioenhancer JNJ-1900 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-advances-cancer-nanotherapeutics-and-bolsters-cash-runway-into-2029?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-advances-cancer-nanotherapeutics-and-bolsters-cash-runway-into-2029?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","LU2430703178.SGD","TRUH","LU0098860793.USD","IE00BLSP4452.SGD","LU2129689605.HKD","LU2750360641.GBP","RXL","LU2133065610.SGD","VHT","IE000SO60NU8.SGD","FTXH","BMED","SG9999001440.SGD","IYH","LU0795875169.SGD","IHE","JNJ","IE000WAW04H5.SGD","LU0234572021.USD","LU0640476718.USD","LU0738911758.USD","IXJ","LU1585245621.USD","LU1066051811.HKD","LU0466842654.USD","LU2089984988.USD","LU0053666078.USD","MEDX","LU2756315318.SGD","LU2471134952.CNY","LU0070217475.USD","LU0122379950.USD","PJP","BK4007","LU2471134523.USD","BK4532","IE00B3T34201.USD","LU1244550494.USD","LU1914381329.SGD","LU2505996681.GBP","LU0057025933.USD","LU1894683348.USD","NANO","FHLC","XLV","LU2756315664.SGD","JDOC","LU0820562030.AUD","IE00BDGV0183.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670941892","title":"France's Nanobiotix H1 Net Loss Widens on Lower Revenue, Absence of 2025 One-Off Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2670941892","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670941892?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:24","pubTimestamp":1790281482,"startTime":"0","endTime":"0","summary":"France's Nanobiotix H1 net loss widens on lower revenue, absence of 2025 one-off gainOverviewFrance-based biotech firm's H1 2026 revenue declined due to prior year one-off non-cash impactNet loss wide","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL1N45G12R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU2896262040.SGD","IE000WAW04H5.SGD","IE0001KFT4U8.USD","LU1506573853.SGD","JDOC","IXJ","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","LU2750360997.AUD","LU1121112475.USD","GDOC","LU0114720955.EUR","LU0098860793.USD","PJP","LU1496350502.SGD","IHE","SGXZ57979304.SGD","LU2430703251.USD","LU0949170772.SGD","VHT","LU0162691827.USD","LU2112291526.USD","XLV","LU1162221912.USD","FTXH","LU0792757196.USD","LU1032466523.USD","MEDX","LU0345769631.USD","SG9999001176.SGD","JNJ","LU0072461881.USD","FHLC","TRUH","BMED","IE0000B7K699.USD","LU0345769128.USD","BK4588","LU1221951046.USD","LU0889566641.SGD","LU2089984988.USD","LU0289961442.SGD","IYH","LU0210528500.USD","LU0545039389.USD","IE00B19Z3581.USD","LU0795875086.SGD","RXL","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670418519","title":"Press Release: Nanobiotix Provides First Half 2026 Operational and Financial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2670418519","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670418519?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:15","pubTimestamp":1790280900,"startTime":"0","endTime":"0","summary":"-- Promising early results reported from full cohort analysis of the. completed dose-escalation and expansion phases of a Phase 1 study. recurrent non-small cell lung cancer  amenable to re-irradiation. -- Strengthened financial position through an oversubscribed EUR86 million. global follow-on offering completed in May 2026, extending cash runway. -- Acceptable safety profile and promising initial efficacy responses. observed in Johnson & Johnson-led Phase 2 CONVERGE study evaluating. Phase 3 NANORAY-312 study evaluating JNJ-1900  in locally. Anderson Cancer Center  presented at 2026 WCLC Meeting:. control rate was 79%. One-year local progression-free survival.  was 61%, and one-year overall survival  was 70% in. clinically meaningful local control using a substantially lower. -- All 24 patients completed treatment with JNJ-1900  plus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","SG9999013999.USD","BK4592","LU1894683264.USD","VHT","TRUH","LU1244550577.SGD","LU1066051225.USD","JDOC","BK4007","LU0289739343.SGD","BMED","LU0345769631.USD","IHE","IE000SO60NU8.SGD","LU1551013342.USD","SG9999001440.SGD","SG9999001176.SGD","FHLC","IE00BN8TJ469.HKD","BK4139","BK4532","BK4534","LU0234570918.USD","LU1629891620.HKD","LU1989771016.USD","GDOC","SG9999001176.USD","LU0057025933.USD","LU0345770308.USD","LU0234572021.USD","IE00B19Z3581.USD","JNJ","LU0210528500.USD","IYH","BK4559","RXL","FTXH","IE00BVYPNW00.USD","IXJ","XLV","SGXZ80539844.SGD","PJP","LU0689472784.USD","LU0738911758.USD","LU2756315664.SGD","LU0994945656.USD","MEDX","LU1674673428.USD","NBTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670490795","title":"FDA approves Welireg and Lenvima combo for ccRCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490795","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490795?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:35","pubTimestamp":1790278513,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration approved Welireg from Merck (MRK) in combination with Lenvima from Eisai (ESAIY) for adults with advanced renal ce...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-welireg-and-lenvima-combo-for-ccrcc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-welireg-and-lenvima-combo-for-ccrcc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1929549753.HKD","LU2125909247.SGD","LU1571399168.USD","SG9999001440.SGD","LU1035773651.USD","LU0265550359.USD","VHT","LU0070302665.USD","LU0985320562.USD","LU0130102774.USD","LU2461242641.AUD","LU0238689110.USD","LU1917777945.USD","LU1989771016.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","FHLC","LU0072461881.USD","LU0208291251.USD","LU0965509010.AUD","IE00B1BXHZ80.USD","LU0265550946.USD","IE00BLSP4452.SGD","SG9999014575.USD","LU0648001328.SGD","LU1116320901.HKD","LU1037948541.HKD","BK4588","LU0320765646.SGD","LU0069063385.USD","LU1116320737.USD","LU0289961442.SGD","LU1923622614.USD","LU2324357040.USD","LU0124676726.USD","MRK","SG9999002232.USD","LU1974910355.USD","LU1585245621.USD","LU0098860793.USD","LU0057025933.USD","LU0289739343.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2361045086.USD","LU1934455277.USD","LU2468319806.SGD","LU1699723380.USD","BK4585","IE00BJJMRZ35.SGD","LU2361044949.HKD","IYH","LU0432979614.USD","LU1093756325.SGD","BK4559","TRUH","LU1941712348.USD","LU0122379950.USD","LU1037948897.HKD","LU0965509101.SGD","LU1989772840.SGD","LU1201861249.SGD","BK4007","LU0859254822.USD","LU2125909593.SGD","LU2357627491.SGD","IE00BBT3K403.USD","SG9999015358.SGD","LU1061106388.HKD","LU0162691827.USD","LU1066053197.SGD","PPH","LU0266013472.USD","LU0211331839.USD","ESAIY","IE00BN8TJ469.HKD","LU2089984988.USD","LU1069347547.HKD","LU2125154778.USD","LU1934455863.HKD","RXL","LU1989772923.USD","LU2106854487.HKD","LU1066051811.HKD","GDOC","BK4534","BMED","LU0868494617.USD","LU2125154935.USD","FTXH","LU2023250504.SGD","LU0965509283.SGD","SG9999001176.USD","XLV","JDOC","SG9999002224.SGD","BK4550","LU0868494708.USD","SG9999014559.SGD","IXJ","SG9999014567.USD","LU0861579265.USD","LU0203345920.USD","LU1162221912.USD","LU1934455194.USD","SGXZ57979304.SGD","LU1983299246.USD","BK4533","LU1093756168.USD","SG9999013999.USD","IE00BFTCPJ56.SGD","LU1941712264.USD","SG9999015341.SGD","IE00BSNM7G36.USD","HRTS","LU1066051225.USD","LU0965508806.USD","LU0320765489.SGD","LU0130517989.USD","LU0289739699.SGD","LU0942090050.USD","LU0058720904.USD","LU0689626769.HKD","LU0472753341.HKD","LU2112291526.USD","LU2360032135.SGD","LU2491049909.HKD","IE0002141913.USD","LU0980610538.SGD","LU1057294990.SGD","LU1430594728.SGD","LU0823416689.USD","LU1066051498.USD","SG9999014542.SGD","LU2361044865.SGD","LU1291159041.SGD","LU0511384066.AUD","LU2491050154.USD","LU0006306889.USD","LU0477156953.USD","LU0203347892.USD","LU2491050071.SGD","IHE","IE00B2B36J28.USD","LU2023250843.SGD","LU2433249047.HKD","BK4516","LU0234572021.USD","IE00BLSP4239.USD","LU0106261372.USD","LU1023059063.AUD","LU1032466523.USD","PAWZ","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670490194","title":"Merck Shares Flat in Volume Spike After FDA Approves Kidney Drug, Last up 0.50% at $148.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490194?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:28","pubTimestamp":1790278130,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL6N45G17P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","LU1934455863.HKD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU2361044865.SGD","LU0965509010.AUD","SGXZ57979304.SGD","LU0320765489.SGD","IE00BSNM7G36.USD","LU2361044949.HKD","LU0203345920.USD","IYH","SG9999001176.SGD","BK4007","LU2106854487.HKD","LU1941712264.USD","IE00B2B36J28.USD","LU2125909247.SGD","LU1057294990.SGD","LU1989771016.USD","LU1923622614.USD","BK4550","LU0942090050.USD","LU1929549753.HKD","JDOC","LU1116320737.USD","LU0861579265.USD","LU1066051811.HKD","LU1699723380.USD","LU0289961442.SGD","LU0069063385.USD","LU0985320562.USD","BK4533","LU0098860793.USD","LU1093756168.USD","LU2361045086.USD","PPH","LU1066051225.USD","LU1201861249.SGD","LU0965509101.SGD","IE00BLSP4239.USD","LU1035773651.USD","LU1066053197.SGD","LU0106261372.USD","LU0238689110.USD","LU0124676726.USD","LU1023059063.AUD","LU1989772923.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","SG9999002224.SGD","LU0432979614.USD","SG9999002232.USD","SG9999014559.SGD","LU2491050154.USD","LU0320765646.SGD","LU0162691827.USD","LU0868494617.USD","LU1430594728.SGD","LU2125154935.USD","FHLC","LU1291159041.SGD","SG9999014542.SGD","BK4516","LU1069347547.HKD","BK4559","LU1116320901.HKD","IE0009355771.USD","LU1162221912.USD","TRUH","LU0265550946.USD","LU2360032135.SGD","LU1934455194.USD","SG9999001440.SGD","LU2089984988.USD","IXJ","LU1037948897.HKD","LU0965509283.SGD","SG9999001176.USD","LU0234572021.USD","LU1917777945.USD","SG9999015358.SGD","BMED","LU0823416689.USD","LU0472753341.HKD","LU1941712348.USD","LU0070302665.USD","LU2125154778.USD","LU1037948541.HKD","LU0072461881.USD","SG9999013999.USD","LU1989772840.SGD","LU1061106388.HKD","LU0058720904.USD","IE00BBT3K403.USD","HRTS","LU0057025933.USD","LU1093756325.SGD","LU2125909593.SGD","SG9999014575.USD","XLV","LU1066051498.USD","LU0130102774.USD","LU1974910355.USD","LU2433249047.HKD","RXL","LU0211331839.USD","LU0289739343.SGD","LU0130517989.USD","LU1585245621.USD","LU0511384066.AUD","LU2491049909.HKD","LU0868494708.USD","LU1032466523.USD","LU0980610538.SGD","BK4585","MRK","IE00BJT1NW94.SGD","LU0266013472.USD","IHE","LU0006306889.USD","LU0122379950.USD","LU2324357040.USD","LU0965508806.USD","LU2023250843.SGD","IE00BN8TJ469.HKD","GDOC","LU0859254822.USD","LU2468319806.SGD","LU2461242641.AUD","LU0289739699.SGD","LU0477156953.USD","LU0203347892.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","FTXH","LU2112291526.USD","LU2023250504.SGD","IE00B1BXHZ80.USD","LU1571399168.USD","SG9999015341.SGD","BK4588","SG9999014567.USD","LU1934455277.USD","PAWZ","LU0265550359.USD","LU1983299246.USD","LU0648001328.SGD","VHT","LU2357627491.SGD","LU0689626769.HKD","LU2491050071.SGD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670490934","title":"FDA Approves Belzutifan in Combination with Lenvatinib for Advanced Renal Cell Carcinoma with a Clear Cell Component","url":"https://stock-news.laohu8.com/highlight/detail?id=2670490934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670490934?lang=en_us&edition=fundamental","pubTime":"2026-09-25 03:16","pubTimestamp":1790277398,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G1BA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","RXL","SG9999015341.SGD","LU0320765489.SGD","SG9999014559.SGD","IE00BBT3K403.USD","LU1035773651.USD","LU0689626769.HKD","IE00B2B36J28.USD","LU1093756168.USD","LU2433249047.HKD","SG9999001440.SGD","LU0472753341.HKD","LU1116320901.HKD","LU1066053197.SGD","FTXH","BK4007","LU1037948897.HKD","LU2023250843.SGD","IE00BSNM7G36.USD","MRK","IE00B4R5TH58.HKD","LU1941712348.USD","BMED","PPH","LU2112291526.USD","LU1023059063.AUD","LU0823416689.USD","LU0203347892.USD","LU0130102774.USD","LU0098860793.USD","LU1066051225.USD","SG9999013999.USD","LU1989772923.USD","LU0289739343.SGD","BK4534","LU1699723380.USD","SG9999014542.SGD","VHT","LU2491050071.SGD","LU1974910355.USD","LU1162221912.USD","IE00BN8TJ469.HKD","TRUH","LU1585245621.USD","LU2361045086.USD","LU0868494708.USD","LU2360032135.SGD","LU1291159041.SGD","LU0266013472.USD","IYH","LU2491050154.USD","LU1201861249.SGD","LU2468319806.SGD","LU1037948541.HKD","SG9999002224.SGD","LU0965509010.AUD","LU0124676726.USD","LU1923622614.USD","LU1917777945.USD","LU0238689110.USD","XLV","LU0289739699.SGD","LU2357627491.SGD","LU0070302665.USD","LU1116320737.USD","LU1929549753.HKD","LU0234572021.USD","SG9999002232.USD","LU0072461881.USD","JDOC","BK4516","LU0006306889.USD","IE00BLSP4239.USD","LU0942090050.USD","BK4559","IE0002141913.USD","LU0320765646.SGD","LU2491049909.HKD","IXJ","LU0211331839.USD","LU0859254822.USD","PAWZ","LU0965509283.SGD","LU0985320562.USD","LU0965509101.SGD","LU2089984988.USD","SG9999014575.USD","IE00BFTCPJ56.SGD","LU0648001328.SGD","LU2125154778.USD","LU0057025933.USD","FHLC","LU1934455277.USD","LU0980610538.SGD","LU0965508806.USD","LU1934455863.HKD","LU2125154935.USD","LU2106854487.HKD","LU1571399168.USD","LU2361044949.HKD","IE0009355771.USD","LU0130517989.USD","LU0477156953.USD","LU2461242641.AUD","IHE","LU0208291251.USD","LU1989771016.USD","LU2023250504.SGD","LU2324357040.USD","LU1941712264.USD","LU1066051498.USD","LU2361044865.SGD","LU0069063385.USD","LU1069347547.HKD","BK4533","LU0106261372.USD","SG9999001176.SGD","SG9999015358.SGD","SGXZ57979304.SGD","LU1983299246.USD","LU0203345920.USD","LU1066051811.HKD","LU0058720904.USD","IE00B1BXHZ80.USD","SG9999014567.USD","LU0265550946.USD","IE000M9KFDE8.USD","LU0265550359.USD","LU2125909247.SGD","LU1093756325.SGD","LU2125909593.SGD","LU1061106388.HKD","BK4550","LU1032466523.USD","LU1989772840.SGD","LU0861579265.USD","BK4588","HRTS","LU0511384066.AUD","LU0289961442.SGD","GDOC","LU0122379950.USD","LU0868494617.USD","LU0162691827.USD","LU0432979614.USD","LU1057294990.SGD","LU1430594728.SGD","IE00BLSP4452.SGD","BK4585","SG9999001176.USD","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492754","title":"Merck Has Two Overlooked Pipeline Catalysts Coming Before Year-End, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492754","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492754?lang=en_us&edition=fundamental","pubTime":"2026-09-25 01:03","pubTimestamp":1790269423,"startTime":"0","endTime":"0","summary":"Merck  has two under-the-radar phase III catalysts due before year-end that carry low investor expectations, creating a positively skewed set up if either reads out positive, UBS said in a note emailed Thursday.The nearer one is phase III BRUNELLO data on MK3000, a Wnt agonist from Merck's 2024 Eyebio deal, in diabetic macular edema. Data is expected around an Oct. 10 placeholder at the American Academy of Ophthalmology meeting, with primary completion for the trial set for Sept. 30, the bank said.UBS said the drug need to prove non-inferiority to Lucentis on vision gains to meet its primary endpoint, while investors will likely demand superiority on a secondary endpoint.The bank also flagged phase III TL1A data due from a second ulcerative colitis study, acquired via the 2023 Prometheus deal, as a second overlooked catalyst.UBS maintained its buy rating on the stock with the price target of $175.Price: 149.64, Change: +1.55, Percent Change: +1.05","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0432979614.USD","SG9999001176.USD","LU2023250504.SGD","LU1699723380.USD","LU1035773651.USD","LU1934455277.USD","SG9999014567.USD","LU0861579265.USD","LU0965509283.SGD","IE0002141913.USD","LU1116320737.USD","LU1066051225.USD","JDOC","LU0289961442.SGD","LU0868494617.USD","BMED","LU2089984988.USD","LU2125154778.USD","BK4550","LU1934455863.HKD","LU1989771016.USD","SG9999015341.SGD","LU2360032135.SGD","FTXH","IE00BSNM7G36.USD","LU0320765646.SGD","LU0072461881.USD","LU1989772923.USD","BK4534","LU1116320901.HKD","LU2491050071.SGD","BK4588","LU2461242641.AUD","LU0965509010.AUD","LU0689626769.HKD","LU0162691827.USD","TRUH","IYH","LU0859254822.USD","BK4585","LU0098860793.USD","LU1983299246.USD","SG9999013999.USD","LU0211331839.USD","SG9999014542.SGD","LU0234572021.USD","LU2361044865.SGD","LU1037948897.HKD","LU1162221912.USD","LU0058720904.USD","LU0124676726.USD","IE00B4R5TH58.HKD","LU1093756168.USD","LU1934455194.USD","LU2023250843.SGD","LU1917777945.USD","LU1093756325.SGD","IE000M9KFDE8.USD","LU1037948541.HKD","PPH","BK4516","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU0980610538.SGD","BK4533","LU0265550359.USD","LU2125909593.SGD","LU0130517989.USD","LU1974910355.USD","LU0069063385.USD","IE00BFTCPJ56.SGD","LU1032466523.USD","IE0009355771.USD","LU2106854487.HKD","LU0238689110.USD","LU0320765489.SGD","VHT","IHE","LU0823416689.USD","LU2491049909.HKD","IE00BBT3K403.USD","LU1057294990.SGD","FHLC","LU2361045086.USD","BK4559","SG9999014575.USD","LU2361044949.HKD","LU2324357040.USD","LU1291159041.SGD","LU1430594728.SGD","LU1929549753.HKD","SG9999014559.SGD","LU0203347892.USD","LU0965509101.SGD","SG9999001440.SGD","LU1923622614.USD","PAWZ","SG9999001176.SGD","LU1023059063.AUD","MRK","LU2112291526.USD","LU0006306889.USD","LU0965508806.USD","SG9999015358.SGD","LU2433249047.HKD","LU1066051498.USD","LU1941712348.USD","LU0203345920.USD","LU1201861249.SGD","XLV","SGXZ57979304.SGD","LU1989772840.SGD","GDOC","SG9999002232.USD","LU2491050154.USD","LU0266013472.USD","LU1585245621.USD","IE00B2B36J28.USD","LU0130102774.USD","LU0985320562.USD","LU1066053197.SGD","LU2125154935.USD","LU2125909247.SGD","LU0208291251.USD","LU1069347547.HKD","IXJ","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU0106261372.USD","LU0477156953.USD","LU0648001328.SGD","LU0265550946.USD","LU0289739343.SGD","LU0070302665.USD","RXL","IE00BLSP4239.USD","LU2468319806.SGD","LU0942090050.USD","LU1066051811.HKD","BK4007","LU1571399168.USD","LU0122379950.USD","LU0511384066.AUD","IE00BN8TJ469.HKD","LU0289739699.SGD","LU0472753341.HKD","LU1061106388.HKD","HRTS","LU1941712264.USD","LU2357627491.SGD","LU0868494708.USD","LU0057025933.USD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669493077","title":"Alert on EOG CFO Appointment Incorrectly Tagged to J&J Withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2669493077","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669493077?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:23","pubTimestamp":1790256223,"startTime":"0","endTime":"0","summary":"ADVISORY-Alert on EOG CFO appointment incorrectly tagged to J&J withdrawnSept 24 (Reuters)-An alert from EOG ResourcesEOG.Nannouncing the appointment of a new CFO was inadvertently tagged to Johnson &","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUAS8RR8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","IE0000B7K699.USD","TRUH","BK4504","LU0943347566.SGD","DRLL","JDOC","IEO","SGXZ80539844.SGD","BK4559","LU2430703251.USD","VHT","JNJ","RXL","MEDX","IYH","LU2756315664.SGD","IXJ","LU0203345920.USD","LU0994945656.USD","LU0208291251.USD","LU1032955483.USD","FHLC","FCG","LU2112291526.USD","IHE","OILT","PJP","LU1280957306.USD","EOG","IE00BGHQF631.EUR","LU1244550494.USD","LU0426412945.USD","PXE","LU2471134879.HKD","LU0964807845.USD","LU1221951129.SGD","BK4550","GDOC","FTXN","LU0203347892.USD","LU0648001328.SGD","LU2237438978.USD","LU0266512127.USD","XLV","IE00BBT3K403.USD","BMED","FTXH","LU0300736492.USD","LU0345769631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669493147","title":"EOG Resources Announces Ann Janssen's Retirement and Jeff Hibbard as Next CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669493147","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669493147?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:10","pubTimestamp":1790255400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUAS8RR8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002141913.USD","IE00B2Q91V27.USD","LU1057294990.SGD","PXE","LU0889566641.SGD","LU1291159041.SGD","LU1551013425.SGD","XLV","BMED","RXL","BK4568","JNJ","FTXN","MEDX","PJP","LU0882574055.USD","IE00BVYPNV92.GBP","GDOC","FCG","LU0640476718.USD","FTXH","IEO","EOG","LU0345770308.USD","LU1244550494.USD","LU2236285917.USD","FHLC","DRLL","LU0203347892.USD","LU0234570918.USD","BK4007","BK4533","LU1261432733.SGD","LU2896262040.SGD","LU0130517989.USD","LU1061106388.HKD","LU2750360997.AUD","JDOC","OILT","VHT","IE00BBT3K403.USD","IE00BLSP4452.SGD","IHE","LU0788109394.HKD","TRUH","IE0009355771.USD","IXJ","BK4585","IYH","LU0345769631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183769643","title":"CSPC Pharma's JMT101 Combined with Osimertinib Achieves Positive Topline Results in Phase III Trial for First-Line Treatment of EGFR ex20ins NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1183769643","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183769643?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:28","pubTimestamp":1790252894,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that the Phase III clinical trial of its developed becotatug (JMT101) in combination with osimertinib for the first-line treatment of locally advanced or metastatic...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU0315179316.USD","LU0140636845.USD","SG9999004220.SGD","LU1152091754.HKD","IBBJ","LU0314109678.HKD","BK1515","LU0501845795.SGD","LU1226287529.USD","LU1993786604.SGD","LU0072913022.USD","BMED","LU0880133367.SGD","LU1813983027.USD","LU2039709279.SGD","KURE","LU1152091168.USD","LU1951186391.HKD","PSYK","IE0008368742.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","MDTX","01093","LU1328277881.USD","BK1521","BK1191","LU1226287875.USD","LU1226288253.USD","LU1807302812.USD","LU1008478684.HKD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","LU1226288170.HKD","LU1226287792.SGD","LU1960683339.HKD","LU0326950275.SGD","IE0008369823.USD","IE00BZ08YR35.GBP","LU0067412154.USD","IE00B543WZ88.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669462942","title":"Merck's Drug for Diabetes-Related Eye Disease Meets Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669462942","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669462942?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:04","pubTimestamp":1790247879,"startTime":"0","endTime":"0","summary":"UPDATE 3-Merck's drug for diabetes-related eye disease meets trial goalSept 24 (Reuters)-MerckMRK.Nsaid on Thursday its injectable drug for a serious eye disease affecting people with diabetes was as ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G0TY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","LU0472753341.HKD","LU0289739343.SGD","LU2324357040.USD","IE00B2B36J28.USD","LU1989772840.SGD","IXJ","LU1066051498.USD","SG9999015341.SGD","MRK","TRUH","LU2023250504.SGD","LU0266013472.USD","LU1116320901.HKD","VHT","BMED","PAWZ","LU0432979614.USD","LU1989771016.USD","BK4550","XLV","LU2491049909.HKD","RXL","SG9999014559.SGD","BK4559","LU0289739699.SGD","LU1061106388.HKD","SG9999002224.SGD","FHLC","HRTS","LU0006306889.USD","LU0203347892.USD","LU0122379950.USD","LU2125154935.USD","GDOC","BK4007","IYH","IHE","LU2433249047.HKD","FTXH","LU0965509283.SGD","LU0511384066.AUD","LU1934455277.USD","LU0477156953.USD","IE000M9KFDE8.USD","BK4516","LU0098860793.USD","LU0985320562.USD","PPH","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669646251","title":"Press Release: Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (fshd) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2669646251","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669646251?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:00","pubTimestamp":1790247600,"startTime":"0","endTime":"0","summary":"-- FDA clearance expands development of forazapadin into a second. degenerative muscle disease with significant unmet medical need. -- FSHD Canada Foundation to provide up to US$5 million in non-dilutive. financing toward the clinical development of forazapadin in FSHD. \"The collaboration between Satellos and the FSHD Canada Foundation provides non-dilutive capital to advance forazapadin's clinical development in FSHD. Under the agreement, the Foundation has agreed to contribute up to US$5 million in milestone payments over the next five quarters in exchange for a capped revenue-sharing interest in future FSHD-related proceeds. The funds are expected to support the IND-cleared Phase 2 randomized, double-blind, placebo-controlled proof-of-concept clinical study designed to evaluate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4139","BMED","BK4585","MSLE","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669464279","title":"Merck Says Remigromig Meets Primary Endpoint in Pivotal Brunello Trial for Diabetic Macular Edema","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464279","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669464279?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:46","pubTimestamp":1790246767,"startTime":"0","endTime":"0","summary":"Merck says remigromig meets primary endpoint in pivotal BRUNELLO trial for diabetic macular edemaMerck reported topline results from the pivotal Phase 2b/3 BRUNELLO trial of remigromig in adults with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL8XG8bK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0265550946.USD","LU0058720904.USD","IE00B4R5TH58.HKD","LU0689626769.HKD","LU1066051811.HKD","LU1032466523.USD","GDOC","IE00BN8TJ469.HKD","TRUH","LU0823416689.USD","LU2491050071.SGD","LU0289739699.SGD","LU2361045086.USD","LU2125909247.SGD","BK4533","LU1057294990.SGD","LU1934455863.HKD","LU1989772923.USD","LU2361044949.HKD","PAWZ","LU2023250843.SGD","BK4516","LU0130102774.USD","BK4534","LU0965509010.AUD","LU1037948897.HKD","LU2023250504.SGD","SG9999001176.SGD","LU0472753341.HKD","LU0980610538.SGD","BK4559","IE00BBT3K403.USD","LU0211331839.USD","LU1934455194.USD","LU1699723380.USD","LU1929549753.HKD","LU2361044865.SGD","LU1162221912.USD","LU2112291526.USD","LU1066051225.USD","LU0648001328.SGD","LU1989771016.USD","SG9999015358.SGD","LU2461242641.AUD","VHT","IXJ","IE0009355771.USD","LU0070302665.USD","FHLC","FTXH","IE00BJT1NW94.SGD","BMED","LU1116320737.USD","LU2125154778.USD","BK4007","LU1941712348.USD","LU1069347547.HKD","LU0511384066.AUD","LU0106261372.USD","LU0266013472.USD","SG9999013999.USD","LU1023059063.AUD","LU1430594728.SGD","LU0289961442.SGD","LU0057025933.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU0477156953.USD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","IE00BLSP4239.USD","LU0965509101.SGD","LU1934455277.USD","LU2125154935.USD","IE00B1BXHZ80.USD","LU0162691827.USD","LU1093756325.SGD","PPH","IHE","LU1061106388.HKD","LU2468319806.SGD","JDOC","LU0861579265.USD","LU2089984988.USD","LU0124676726.USD","LU0320765646.SGD","LU2491049909.HKD","SGXZ57979304.SGD","LU0072461881.USD","LU1201861249.SGD","LU0985320562.USD","SG9999002232.USD","LU1585245621.USD","LU0320765489.SGD","SG9999001440.SGD","LU0265550359.USD","LU1037948541.HKD","LU1974910355.USD","LU2357627491.SGD","LU0069063385.USD","IYH","LU0098860793.USD","LU0432979614.USD","SG9999014542.SGD","LU0130517989.USD","LU1983299246.USD","SG9999015341.SGD","LU0122379950.USD","LU1066053197.SGD","LU1035773651.USD","LU0965508806.USD","SG9999002224.SGD","LU1291159041.SGD","LU0203345920.USD","IE00BSNM7G36.USD","LU2360032135.SGD","LU1923622614.USD","SG9999014559.SGD","SG9999014575.USD","LU1116320901.HKD","BK4585","LU0942090050.USD","LU1066051498.USD","LU1093756168.USD","LU2324357040.USD","HRTS","LU2125909593.SGD","IE00BJJMRZ35.SGD","RXL","SG9999001176.USD","IE00B2B36J28.USD","LU0203347892.USD","LU1989772840.SGD","LU0859254822.USD","LU0238689110.USD","LU0868494617.USD","LU2491050154.USD","BK4588","LU2106854487.HKD","LU0006306889.USD","LU0868494708.USD","SG9999014567.USD","LU1917777945.USD","LU1571399168.USD","MRK","LU1941712264.USD","LU0965509283.SGD","XLV","LU2433249047.HKD","LU0289739343.SGD","BK4550","LU0208291251.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669642514","title":"Merck & Co - Higher Rates of Pdr, Vitreous Hemorrhage, and Discontinuations with Remigromig","url":"https://stock-news.laohu8.com/highlight/detail?id=2669642514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669642514?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:45","pubTimestamp":1790246700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUAC1R4LY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125909247.SGD","LU0130517989.USD","MRK","IXJ","HRTS","BK4559","LU0162691827.USD","LU1023059063.AUD","LU2468319806.SGD","BK4534","FHLC","LU1093756325.SGD","IYH","PPH","LU1585245621.USD","LU0238689110.USD","LU2491050071.SGD","LU0070302665.USD","IE00B1BXHZ80.USD","LU1037948897.HKD","IE00BLSP4239.USD","LU0859254822.USD","LU2461242641.AUD","LU0006306889.USD","VHT","BK4585","LU2112291526.USD","LU0265550946.USD","LU1032466523.USD","LU1941712348.USD","LU1989772840.SGD","SG9999013999.USD","LU1430594728.SGD","LU0106261372.USD","SGXZ57979304.SGD","SG9999002224.SGD","RXL","LU1699723380.USD","LU1989772923.USD","SG9999014559.SGD","LU0980610538.SGD","LU1983299246.USD","LU0320765489.SGD","LU1974910355.USD","LU2125909593.SGD","LU2125154935.USD","LU0868494617.USD","LU2361044949.HKD","SG9999002232.USD","LU2106854487.HKD","LU0965509101.SGD","LU1291159041.SGD","IE00BJJMRZ35.SGD","JDOC","LU0098860793.USD","LU0477156953.USD","LU2023250843.SGD","SG9999001176.USD","LU0124676726.USD","LU0823416689.USD","IE0002141913.USD","LU0320765646.SGD","IE00BLSP4452.SGD","IHE","SG9999014567.USD","LU1162221912.USD","IE00BSNM7G36.USD","LU0211331839.USD","TRUH","LU2491049909.HKD","LU0472753341.HKD","IE00BN8TJ469.HKD","IE00BJT1NW94.SGD","LU0289739343.SGD","LU0942090050.USD","LU0965508806.USD","LU2491050154.USD","SG9999014575.USD","LU0122379950.USD","LU2361045086.USD","LU0432979614.USD","IE00BBT3K403.USD","LU0203347892.USD","LU0868494708.USD","LU0965509283.SGD","LU0648001328.SGD","LU1116320737.USD","LU2357627491.SGD","LU0289961442.SGD","BK4550","SG9999015358.SGD","BMED","LU1093756168.USD","LU1934455277.USD","LU0689626769.HKD","IE00B2B36J28.USD","LU1929549753.HKD","LU0985320562.USD","LU2360032135.SGD","GDOC","LU0072461881.USD","LU0265550359.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","SG9999001176.SGD","LU1061106388.HKD","LU1037948541.HKD","LU0203345920.USD","BK4588","IE000M9KFDE8.USD","LU1116320901.HKD","LU2324357040.USD","LU1069347547.HKD","LU0069063385.USD","SG9999015341.SGD","LU1035773651.USD","IE0009355771.USD","SG9999014542.SGD","LU1066053197.SGD","LU2125154778.USD","LU1941712264.USD","LU0208291251.USD","PAWZ","BK4516","LU1917777945.USD","LU0058720904.USD","LU1066051498.USD","LU1066051225.USD","LU0289739699.SGD","XLV","LU0965509010.AUD","LU1934455194.USD","LU1057294990.SGD","LU0861579265.USD","LU2361044865.SGD","BK4007","LU1934455863.HKD","SG9999001440.SGD","LU2023250504.SGD","LU0234572021.USD","LU0130102774.USD","LU1066051811.HKD","IE00B4R5TH58.HKD","LU1201861249.SGD","LU1989771016.USD","LU0511384066.AUD","LU2089984988.USD","LU0266013472.USD","LU2433249047.HKD","BK4533","LU1923622614.USD","FTXH","LU0057025933.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669546425","title":"Merck’s Remigromig, a Tri-Specific Agonist of the Wingless-Related Integration Site (Wnt) Pathway, Met Primary Endpoint in the Pivotal Phase 2B/3 Brunello Study of Adults with Diabetic Macular Edema","url":"https://stock-news.laohu8.com/highlight/detail?id=2669546425","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669546425?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:45","pubTimestamp":1790246700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUAC1R4LY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B1BXHZ80.USD","LU1069347547.HKD","LU0098860793.USD","LU0234572021.USD","LU2468319806.SGD","LU2112291526.USD","LU0965509101.SGD","LU2357627491.SGD","LU0965509283.SGD","LU0211331839.USD","IE00BJT1NW94.SGD","LU0289961442.SGD","PAWZ","LU0130517989.USD","IE0009355771.USD","LU1116320737.USD","LU1037948541.HKD","LU0320765489.SGD","LU0124676726.USD","IE00BSNM7G36.USD","LU0203345920.USD","LU0472753341.HKD","LU1037948897.HKD","LU0477156953.USD","LU0511384066.AUD","LU1116320901.HKD","LU1066051498.USD","SG9999015341.SGD","LU0006306889.USD","LU0072461881.USD","JDOC","LU0965509010.AUD","LU1162221912.USD","LU1974910355.USD","IE00BBT3K403.USD","SG9999002224.SGD","LU1093756325.SGD","LU0265550359.USD","SG9999001440.SGD","LU0868494708.USD","LU0648001328.SGD","LU2491049909.HKD","LU1983299246.USD","MRK","IE000M9KFDE8.USD","LU1585245621.USD","RXL","LU1035773651.USD","LU1430594728.SGD","LU1571399168.USD","LU1699723380.USD","LU2433249047.HKD","LU0289739343.SGD","LU1989771016.USD","LU1989772923.USD","LU0823416689.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU2361045086.USD","SG9999014559.SGD","IYH","SGXZ57979304.SGD","LU2106854487.HKD","LU2023250504.SGD","LU0122379950.USD","LU0861579265.USD","BK4534","BMED","LU0106261372.USD","LU0289739699.SGD","IHE","LU0069063385.USD","LU1066051225.USD","XLV","SG9999001176.SGD","TRUH","HRTS","LU1934455194.USD","VHT","IE00BLSP4452.SGD","BK4550","LU1291159041.SGD","IE00BLSP4239.USD","LU1023059063.AUD","BK4585","LU2360032135.SGD","LU1923622614.USD","SG9999014542.SGD","LU1057294990.SGD","PPH","LU1093756168.USD","IE0002141913.USD","LU0203347892.USD","LU2491050154.USD","LU2361044949.HKD","LU1061106388.HKD","LU0057025933.USD","LU1941712348.USD","BK4533","LU1934455277.USD","LU0965508806.USD","LU0432979614.USD","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU1032466523.USD","LU0868494617.USD","SG9999013999.USD","LU0238689110.USD","LU0942090050.USD","LU0058720904.USD","LU0130102774.USD","LU0208291251.USD","GDOC","IE00BFTCPJ56.SGD","LU1934455863.HKD","LU1917777945.USD","SG9999001176.USD","LU1989772840.SGD","LU0266013472.USD","BK4516","LU2125909593.SGD","FTXH","LU2361044865.SGD","LU0689626769.HKD","SG9999015358.SGD","LU2125154935.USD","LU0985320562.USD","IXJ","LU0162691827.USD","LU2125154778.USD","BK4007","LU0320765646.SGD","LU1941712264.USD","LU0265550946.USD","LU2023250843.SGD","SG9999014567.USD","BK4559","SG9999014575.USD","LU1201861249.SGD","LU2491050071.SGD","SG9999002232.USD","LU0070302665.USD","BK4588","LU0980610538.SGD","LU2089984988.USD","LU2461242641.AUD","IE00BN8TJ469.HKD","LU2324357040.USD","LU0859254822.USD","LU1929549753.HKD","LU2125909247.SGD","LU1066051811.HKD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":8,"totalSize":223,"code":"91000000","status":"200"}]}}